Preprint / Version 2

Structural basis of fatty acid activation and transport by human FATP2

This article is a preprint and has not been certified by peer review.
Now published in Nature Communications. doi: 10.1038/s41467-026-76658-2

Authors

Categories
Keywords
Fatty acid; Transport; FATP; Membrane Protein; Drug Target; LCFA; VLCFA; Acyl-CoA synthetase; Lipid Metabolism; β-oxidation

Abstract

Fatty acid transport proteins (FATPs) are responsible for efficient uptake of fatty acids (FAs), essential biomolecules that play critical roles in development and growth. However, the lack of three-dimensional structures of FATPs has hindered our understanding of their mechanisms. Here, we report two cryo-EM structures of human FATP2a: wild-type (WT) FATP2a in intermediate state at 2.93 Å and a catalytic mutant of FATP2a in pre-catalytic state at 2.76 Å. In the two structures, both the oleoyl-AMP intermediate and ATP occupy the same central pocket with the acyl group of oleoyl-AMP pointing upwards and placed in a hydrophobic tunnel while the phosphate groups of ATP pointing downwards and interacting with a central loop. The structures also reveal that FAs from the membrane must undergo a two-step translocation to access the catalytic center. The binding of a new FA before the completion of a working cycle may be crucial to ensure the catalytic and transport efficiency. Furthermore, we demonstrate that FATP2a transport FAs, strictly dependent on the activation of FAs through the acyl-CoA synthetase activity. Our findings provide important insights into the working mechanism of FATPs and offer a structural basis for the development of inhibitors targeting FATPs to treat related diseases.

References

1 Houten, S. M., Violante, S., Ventura, F. V. & Wanders, R. J. The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders. Annu Rev Physiol 78, 23-44, doi:10.1146/annurev-physiol-021115-105045 (2016).

2 Nohturfft, A. & Zhang, S. C. Coordination of lipid metabolism in membrane biogenesis. Annu Rev Cell Dev Biol 25, 539-566, doi:10.1146/annurev.cellbio.24.110707.175344 (2009).

3 Zadoorian, A., Du, X. & Yang, H. Lipid droplet biogenesis and functions in health and disease. Nat Rev Endocrinol 19, 443-459, doi:10.1038/s41574-023-00845-0 (2023).

4 Brennan, E., Kantharidis, P., Cooper, M. E. & Godson, C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol 17, 725-739, doi:10.1038/s41581-021-00454-y (2021).

5 Samovski, D., Jacome-Sosa, M. & Abumrad, N. A. Fatty Acid Transport and Signaling: Mechanisms and Physiological Implications. Annu Rev Physiol 85, 317-337, doi:10.1146/annurev-physiol-032122-030352 (2023).

6 Spector, A. A. & Yorek, M. A. Membrane lipid composition and cellular function. J Lipid Res 26, 1015-1035 (1985).

7 Grevengoed, T. J., Klett, E. L. & Coleman, R. A. Acyl-CoA metabolism and partitioning. Annu Rev Nutr 34, 1-30, doi:10.1146/annurev-nutr-071813-105541 (2014).

8 Dutta-Roy, A. K. Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell Mol Life Sci 57, 1360-1372, doi:10.1007/pl00000621 (2000).

9 Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab 31, 62-76, doi:10.1016/j.cmet.2019.11.010 (2020).

10 Kleinfeld, A. M., Chu, P. & Romero, C. Transport of long-chain native fatty acids across lipid bilayer membranes indicates that transbilayer flip-flop is rate limiting. Biochemistry 36, 14146-14158, doi:10.1021/bi971440e (1997).

11 Hirsch, D., Stahl, A. & Lodish, H. F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A 95, 8625-8629, doi:10.1073/pnas.95.15.8625 (1998).

12 Stahl, A. et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 4, 299-308, doi:10.1016/s1097-2765(00)80332-9 (1999).

13 Gimeno, R. E. et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 278, 49512-49516, doi:10.1074/jbc.M309759200 (2003).

14 Schaffer, J. E. & Lodish, H. F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79, 427-436, doi:10.1016/0092-8674(94)90252-6 (1994).

15 Black, P. N., Ahowesso, C., Montefusco, D., Saini, N. & DiRusso, C. C. Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids. Medchemcomm 7, 612-622, doi:10.1039/c6md00043f (2016).

16 Melton, E. M., Cerny, R. L., DiRusso, C. C. & Black, P. N. Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids. Biochem Biophys Res Commun 440, 743-748, doi:10.1016/j.bbrc.2013.09.137 (2013).

17 Coe, N. R., Smith, A. J., Frohnert, B. I., Watkins, P. A. & Bernlohr, D. A. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 274, 36300-36304, doi:10.1074/jbc.274.51.36300 (1999).

18 Falcon, A. et al. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am J Physiol Endocrinol Metab 299, E384-393, doi:10.1152/ajpendo.00226.2010 (2010).

19 Anderson, C. M. & Stahl, A. SLC27 fatty acid transport proteins. Mol Aspects Med 34, 516-528, doi:10.1016/j.mam.2012.07.010 (2013).

20 Veglia, F. et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature 569, 73-78, doi:10.1038/s41586-019-1118-2 (2019).

21 Glatz, J. F., Luiken, J. J. & Bonen, A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90, 367-417, doi:10.1152/physrev.00003.2009 (2010).

22 Hagberg, C. E. et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464, 917-921, doi:10.1038/nature08945 (2010).

23 Schulze, P. C., Drosatos, K. & Goldberg, I. J. Lipid Use and Misuse by the Heart. Circ Res 118, 1736-1751, doi:10.1161/circresaha.116.306842 (2016).

24 Michos, E. D., McEvoy, J. W. & Blumenthal, R. S. Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease. N Engl J Med 381, 1557-1567, doi:10.1056/NEJMra1806939 (2019).

25 Carlson, M. L. et al. The Peptidisc, a simple method for stabilizing membrane proteins in detergent-free solution. Elife 7, doi:10.7554/eLife.34085 (2018).

26 Stahl, A., Evans, J. G., Pattel, S., Hirsch, D. & Lodish, H. F. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell 2, 477-488, doi:10.1016/s1534-5807(02)00143-0 (2002).

27 Kolahi, K., Louey, S., Varlamov, O. & Thornburg, K. Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells. PLoS One 11, e0153522, doi:10.1371/journal.pone.0153522 (2016).

28 Watkins, P. A., Maiguel, D., Jia, Z. & Pevsner, J. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res 48, 2736-2750, doi:10.1194/jlr.M700378-JLR200 (2007).

29 Stuhlsatz-Krouper, S. M., Bennett, N. E. & Schaffer, J. E. Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. J Biol Chem 273, 28642-28650, doi:10.1074/jbc.273.44.28642 (1998).

30 Stuhlsatz-Krouper, S. M., Bennett, N. E. & Schaffer, J. E. Molecular aspects of fatty acid transport: mutations in the IYTSGTTGXPK motif impair fatty acid transport protein function. Prostaglandins Leukot Essent Fatty Acids 60, 285-289, doi:10.1016/s0952-3278(99)80001-5 (1999).

31 Kochan, G., Pilka, E. S., von Delft, F., Oppermann, U. & Yue, W. W. Structural snapshots for the conformation-dependent catalysis by human medium-chain acyl-coenzyme A synthetase ACSM2A. J Mol Biol 388, 997-1008, doi:10.1016/j.jmb.2009.03.064 (2009).

32 Horswill, A. R. & Escalante-Semerena, J. C. Characterization of the propionyl-CoA synthetase (PrpE) enzyme of Salmonella enterica: residue Lys592 is required for propionyl-AMP synthesis. Biochemistry 41, 2379-2387, doi:10.1021/bi015647q (2002).

33 Reger, A. S., Carney, J. M. & Gulick, A. M. Biochemical and crystallographic analysis of substrate binding and conformational changes in acetyl-CoA synthetase. Biochemistry 46, 6536-6546, doi:10.1021/bi6026506 (2007).

34 Hisanaga, Y. et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J Biol Chem 279, 31717-31726, doi:10.1074/jbc.M400100200 (2004).

35 Kumar, M. et al. Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications. Int J Biol Macromol 244, 125328, doi:10.1016/j.ijbiomac.2023.125328 (2023).

36 Sandoval, A., Chokshi, A., Jesch, E. D., Black, P. N. & Dirusso, C. C. Identification and characterization of small compound inhibitors of human FATP2. Biochem Pharmacol 79, 990-999, doi:10.1016/j.bcp.2009.11.008 (2010).

37 Ahowesso, C. et al. Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death. Biochem Pharmacol 98, 167-181, doi:10.1016/j.bcp.2015.09.004 (2015).

38 Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290-296, doi:10.1038/nmeth.4169 (2017).

39 Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat Methods 17, 1214-1221, doi:10.1038/s41592-020-00990-8 (2020).

40 Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370-383.e313, doi:10.1016/j.cell.2020.11.043 (2021).

41 Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583-589, doi:10.1038/s41586-021-03819-2 (2021).

42 Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493-500, doi:10.1038/s41586-024-07487-w (2024).

43 Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132, doi:10.1107/s0907444904019158 (2004).

44 Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D Struct Biol 74, 531-544, doi:10.1107/s2059798318006551 (2018).

45 Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35, W375-383, doi:10.1093/nar/gkm216 (2007).

46 DeLano, W. L. The PyMOL Molecular Graphics System., <http://www.pymol.org> (2002).

47 Pettersen, E. F. et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612, doi:10.1002/jcc.20084 (2004).

48 Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci 30, 70-82, doi:10.1002/pro.3943 (2021).

Metrics

Favorites: 1
Views: 3860
Downloads: 1250

Downloads

Posted

2026-08-11

Versions

How to Cite

Li, A., Shi, J., Xu, X., Yang, Y., Feng, S., & Ma, D. (2026). Structural basis of fatty acid activation and transport by human FATP2. LangTaoSha Preprint Server. https://doi.org/10.65215/LTSpreprints.2025.12.29.000072

Download Citation

Declaration of Competing Interests

The authors declare no competing interests to disclose.